Abstract
This article focuses on several promising candidate biomarkers that may soon make their transition to the realm of clinical management of bladder cancer. Presented are superficial and muscle-invasive urothelial carcinoma of the bladder and the genetic tests currently available in testing for diagnosis and prognosis of these diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 843-858 |
Number of pages | 16 |
Journal | Surgical Pathology Clinics |
Volume | 5 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1 2012 |
Keywords
- Biomarkers
- Molecular bladder
- Urothelial carcinoma
ASJC Scopus subject areas
- Surgery
- Pathology and Forensic Medicine